NeuroOne Medical Technologies is a medical device company that develops and commercializes minimally invasive neurological solutions for epilepsy, Parkinson's disease, pain management, and drug delivery. The company has received FDA clearance for four devices—temporary cortical and depth electrodes for brain monitoring, and two radiofrequency ablation systems for brain and nerve lesioning—which are distributed globally through Zimmer Biomet, generating millions in annual revenue. NeuroOne leverages proprietary thin-film electrode technology to create integrated diagnostic and therapeutic platforms, with additional products in development for spinal cord stimulation, basivertebral nerve ablation, and drug delivery to the brain, targeting large underserved patient populations in epilepsy, chronic pain, and neurodegenerative conditions.